Why the study?
Do intravascular ultrasound and angiographic morphological features of culprit lesions differ between patients presenting with STEMI versus NSTEACS?
Do intravascular ultrasound and angiographic morphological features of culprit lesions differ between patients presenting with STEMI versus NSTEACS?
Culprit lesions in STEMI exhibit greater morphological vulnerability, including more frequent plaque rupture, larger necrotic cores, and microcalcification, compared to those in NSTEACS.
Suggests distinct ACS pathobiology; hypothesis-generating for morphology-guided strategies pending prospective data.
Background: Rupture of vulnerable plaque is a major cause of acute coronary syndrome (ACS), with some clots being partially or totally occlusive. However, it is not clear why some plaque ruptures lead to ST-segment elevation myocardial infarction (STEMI), whereas others cause non-ST-segment elevation ACS (NSTEACS). Methods: A consecutive 158 ACS pts whose culprit lesions imaged by preintervention intravascular ultrasound (IVUS) were enrolled (STEMI=81; NSTEACS=77). IVUS and angiographic findings of culprit lesions, and clinical demographics were compared between the groups. Results: Pts’ characteristics were identical except lower rate of prior statin use in pts with STEMI (20% vs 44%, p=0.001). Angiographic complex Ambrose lesion and thrombus were more common in STEMI than in NSTEACS (83% vs 62%, p=0.002; 51% vs 5%, p<0.0001, respectively). In contrast, SYNTAX score was lower in STEMI (9±5 vs 12±7, p=0.01). In pts with STEMI, culprit echogenicity on IVUS was more hypoechoic (63% vs 40%, p=0.01), and the incidence of plaque rupture, attenuation and “microcalcification (granular calcification with attenuation)” were higher (53% vs 18%, p<0.0001; 86% vs 68%, p=0.01; 75% vs 61%, p=0.04, respectively). Further, the max area of ruptured cavity, echo lucent zone and arc of microcalcification were significantly greater in STEMI compared with NSTEACS (1.8±1.0mm 2 vs 1.1±0.9mm 2 , p=0.006; 1.5±0.7mm 2 vs 1.2±0.8mm 2 , p=0.004; 100±55° vs 77±51°, p=0.01, respectively). On quantitative and color-coded IVUS, vessel and plaque area were significantly larger at min lumen area (MLA) site in STEMI (16.6±5.4mm 2 vs 14.2±5.5mm 2 , p=0.003; 13.9±5.1mm 2 vs 11.6±5.2mm 2 , p=0.003, respectively) and at max vessel area site (20.2±5.4mm 2 vs 18.0±6.4mm 2 , p=0.007; 13.7±4.1mm 2 vs 12.2±5.6mm 2 , p=0.02, respectively), leading to larger necrotic (6.8±3.8mm 2 vs 4.8±3.9mm 2 , p=0.04) and lipidic (1.5±0.6mm 2 vs 1.1±0.6mm 2 , p=0.02) tissue area at MLA site in STEMI as well as fibrotic tissue (7.3±2.5mm 2 vs 5.7±2.2mm 2 , p=0.03). Conclusion: Morphological feature (outward vessel remodeling and IVUS vulnerability [e.g. greater ruptured cavity, larger necrotic and lipidic tissue, and microcalcification]) of culprit lesions might relate to clinical presentation of pts with ACS.
No takes yet. Share an insight, caveat, or question.
Takaoka et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: